Click to view 3D structure | Monoglyceride lipase | Q99685 | Humans | Predicted (SEA) | 264.454 |
Click to view 3D structure | Fatty-acid amide hydrolase 1 | P97612 | Rattus norvegicus | Predicted (SEA) | 599.128 |
Click to view 3D structure | Kynurenine--oxoglutarate transaminase 1 | Q16773 | Humans | Predicted (SEA) | 31.8403 |
Click to view 3D structure | 72 kDa type IV collagenase | P08253 | Humans | Predicted (SEA) | 1739.85 |
Click to view 3D structure | Matrix metalloproteinase-9 | P14780 | Humans | Predicted (SEA) | 1492.99 |
Click to view 3D structure | 15-cis-phytoene desaturase | P26294 | Synechococcus elongatus (strain PCC 7942) (Anacystis nidulans R2) | Predicted (SEA) | 179.442 |
Click to view 3D structure | Sodium-dependent serotonin transporter | P31645 | Humans | Predicted (SEA) | 2660.81 |
Click to view 3D structure | Cytochrome P450 2C9 | P11712 | Humans | Predicted (SEA) | 5580.54 |
Click to view 3D structure | Interstitial collagenase | P03956 | Humans | Predicted (SEA) | 1778.39 |
Click to view 3D structure | Matrix metalloproteinase-14 | P50281 | Humans | Predicted (SEA) | 1403.93 |
Click to view 3D structure | Collagenase 3 | P45452 | Humans | Predicted (SEA) | 1876.4 |
Click to view 3D structure | Prostaglandin G/H synthase 1 | P05979 | Ovis aries | Predicted (SEA) | 796.865 |
Click to view 3D structure | Prostaglandin G/H synthase 2 | P35354 | Humans | Predicted (SEA) | 1553.79 |
Click to view 3D structure | Macrophage metalloelastase | P39900 | Humans | Predicted (SEA) | 1480.69 |
Click to view 3D structure | Cytochrome P450 2D6 | P10635 | Humans | Predicted (SEA) | 5902.14 |
Click to view 3D structure | Stromelysin-1 | P08254 | Humans | Predicted (SEA) | 1742.19 |
Click to view 3D structure | Fatty-acid amide hydrolase 1 | O00519 | Humans | Predicted (SEA) | 1543.13 |
Click to view 3D structure | RNA-directed RNA polymerase | O39930 | Hepatitis C Virus | Predicted (SEA) | 163.717 |
Click to view 3D structure | Kappa-type opioid receptor | P41145 | Humans | Predicted (SEA) | 3590.33 |
Click to view 3D structure | Cathepsin B | P07858 | Humans | Predicted (SEA) | 1396.46 |
Click to view 3D structure | E3 ubiquitin-protein ligase RNF4 | P78317 | Humans | Predicted (SEA) | 190.886 |
Click to view 3D structure | Muscarinic acetylcholine receptor M5 | P08912 | Humans | Predicted (SEA) | 2208.74 |
Click to view 3D structure | Procathepsin L | P07711 | Humans | Predicted (SEA) | 1393.66 |
Click to view 3D structure | Cathepsin K | P43235 | Humans | Predicted (SEA) | 1177.24 |
Click to view 3D structure | Voltage-gated inwardly rectifying potassium channel KCNH2 | Q12809 | Humans | Predicted (SEA) | 6493.71 |
Click to view 3D structure | Nuclear receptor subfamily 1 group I member 2 | O75469 | Humans | Known | Not Available |
Click to view 3D structure | Sodium channel protein type 1 subunit alpha | P35498 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 10 subunit alpha | Q9Y5Y9 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 11 subunit alpha | Q9UI33 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 2 subunit alpha | Q99250 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 3 subunit alpha | Q9NY46 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 4 subunit alpha | P35499 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 5 subunit alpha | Q14524 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 8 subunit alpha | Q9UQD0 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel protein type 9 subunit alpha | Q15858 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-1 | Q07699 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-2 | O60939 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-3 | Q9NY72 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Sodium channel regulatory subunit beta-4 | Q8IWT1 | Humans | Known | This pyrethroid exerts its profound effect by prolonging the open phase of the sodium channel gates when a nerve cell is excited. This pyrethroid is a axonic poison that block the closing of the sodium gates in the nerves, and, thus, prolongs the return of the membrane potential to its resting state leading to hyperactivity of the nervous system which can result in paralysis and/or death. Type I Pyrethroid esters (lacking the alpha-cyano substituents) affect sodium channels in nerve membranes, causing repetitive (sensory, motor) neuronal discharge and a prolonged negative afterpotential, the effects being quite similar to those produced by DDT (L857, A560). |
Click to view 3D structure | Calcium-transporting ATPase type 2C member 1 | P98194 | Humans | Known | This pyrethroid inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10) |
Click to view 3D structure | Estrogen receptor | P03372 | Humans | Known | Not Available |
Click to view 3D structure | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | O14983 | Humans | Known | This pyrethroid inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10) |
Click to view 3D structure | Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | P16615 | Humans | Known | This pyrethroid inhibits Na+/K+ ATPase and Ca2+ and Mg2+ ATPase, which are essential for the transport of calcium across membranes. This results in the accumulation of intracellular free calcium ions, which promotes release of neurotransmitters from storage vesicles, the subsequent depolarization of adjacent neurons, and the propagation of stimuli throughout the central nervous system. (T10) |
Click to view 3D structure | Urokinase plasminogen activator surface receptor | Q03405 | Humans | Known | Not Available |
Click to view 3D structure | 5-hydroxytryptamine receptor 7 | P34969 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 2D6 | P10635 | Humans | Known | Not Available |
Click to view 3D structure | Bile acid receptor | Q96RI1 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 1A2 | P05177 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 2B6 | P20813 | Humans | Known | Not Available |
Click to view 3D structure | Collagen alpha-1(III) chain | P02461 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 3A4 | P08684 | Humans | Known | Not Available |
Click to view 3D structure | Prostaglandin E2 receptor EP2 subtype | P43116 | Humans | Known | Not Available |
Click to view 3D structure | Sulfotransferase 2A1 | Q06520 | Humans | Known | Not Available |
Click to view 3D structure | 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | O15528 | Humans | Known | Not Available |
Click to view 3D structure | Vitamin D3 receptor | P11473 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 1A1 | P04798 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 2C19 | P33261 | Humans | Known | Not Available |
Click to view 3D structure | Peroxisome proliferator-activated receptor alpha | Q07869 | Humans | Known | Not Available |
Click to view 3D structure | Cytochrome P450 2C9 | P11712 | Humans | Known | Not Available |
Click to view 3D structure | UDP-glucuronosyltransferase 1A1 | P22309 | Humans | Known | Not Available |